Mutations in the reverse transcriptase gene of HIV type 1 from subjects after stavudine-didanosine dual therapy

AIDS Res Hum Retroviruses. 2000 May 20;16(8):821-3. doi: 10.1089/088922200308828.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Didanosine / therapeutic use*
  • Drug Therapy, Combination
  • Genes, Viral
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Reverse Transcriptase / genetics*
  • HIV-1 / enzymology
  • HIV-1 / genetics
  • Humans
  • Mutation*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Sequence Analysis, DNA
  • Stavudine / therapeutic use*

Substances

  • Anti-HIV Agents
  • Reverse Transcriptase Inhibitors
  • Stavudine
  • HIV Reverse Transcriptase
  • Didanosine